“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises

Abstract Background Since the onset of the COVID-19 pandemic, overdose rates in North America have continued to rise, with more than 100,000 drug poisoning deaths in the past year. Amidst an increasingly toxic drug supply, the pandemic disrupted essential substance use treatment and harm reduction s...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook, Scott MacDonald, Scott Harrison, Julie Lajeunesse, David Byres, Martin Schechter, Eugenia Oviedo-Joekes
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2023-04-01
Rangatū:	Harm Reduction Journal
Ngā marau:	Injectable opioid agonist treatment COVID-19 pandemic Substance use Canada
Urunga tuihono:	https://doi.org/10.1186/s12954-023-00779-w
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!